DK1070255T3 - Fremgangsmåde til detektering af komplekset af IGFBP-3 med IGF og/eller ALS - Google Patents

Fremgangsmåde til detektering af komplekset af IGFBP-3 med IGF og/eller ALS

Info

Publication number
DK1070255T3
DK1070255T3 DK99911282T DK99911282T DK1070255T3 DK 1070255 T3 DK1070255 T3 DK 1070255T3 DK 99911282 T DK99911282 T DK 99911282T DK 99911282 T DK99911282 T DK 99911282T DK 1070255 T3 DK1070255 T3 DK 1070255T3
Authority
DK
Denmark
Prior art keywords
complex
igfbp
igf
als
detecting
Prior art date
Application number
DK99911282T
Other languages
English (en)
Inventor
M Javad Khosravi
Jehangir Mistry
Anastasia Diamandi
Original Assignee
Diagnostic Systems Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Systems Lab Inc filed Critical Diagnostic Systems Lab Inc
Application granted granted Critical
Publication of DK1070255T3 publication Critical patent/DK1070255T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99911282T 1998-03-09 1999-03-08 Fremgangsmåde til detektering af komplekset af IGFBP-3 med IGF og/eller ALS DK1070255T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/036,845 US6248546B1 (en) 1998-03-09 1998-03-09 Assay of IGFBP complex
EP99911282A EP1070255B1 (en) 1998-03-09 1999-03-08 Method to detect the complex of igfbp-3 with igf and/or als

Publications (1)

Publication Number Publication Date
DK1070255T3 true DK1070255T3 (da) 2005-10-03

Family

ID=21890976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99911282T DK1070255T3 (da) 1998-03-09 1999-03-08 Fremgangsmåde til detektering af komplekset af IGFBP-3 med IGF og/eller ALS

Country Status (11)

Country Link
US (1) US6248546B1 (da)
EP (1) EP1070255B1 (da)
AT (1) ATE304708T1 (da)
AU (1) AU760099B2 (da)
CA (1) CA2323450C (da)
DE (1) DE69927255T2 (da)
DK (1) DK1070255T3 (da)
ES (1) ES2249887T3 (da)
NZ (1) NZ507400A (da)
RU (1) RU2206897C2 (da)
WO (1) WO1999046597A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080064044A9 (en) * 1995-05-23 2008-03-13 Nelson Randall W Analysis of insulin-like growth factors from biological fluids by the use of affinity-based mass spectrometric methods
US6448086B1 (en) 2000-01-18 2002-09-10 Diagnostic Systems Laboratories, Inc. Insulin-like growth factor system and cancer
WO2002090580A1 (en) * 2001-05-03 2002-11-14 National Cancer Centre Of Singapore Pte Ltd Identifying liver cancer by detecting aberrant expression of insulin like growth factor binding protein
US7402397B2 (en) 2002-05-21 2008-07-22 Monogram Biosciences, Inc. Detecting and profiling molecular complexes
US20040229380A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB heterodimers as biomarkers
US20040229294A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
PT1535068E (pt) 2002-08-13 2010-07-01 N Dia Inc DISPOSITIVOS E MéTODOS PARA DETECTAR FLUIDO AMNIËTICO EM SECREÎES VAGINAIS
US20040049351A1 (en) * 2002-08-28 2004-03-11 Matson Robert S. Immunosorbent assay in microarray format
US7196169B2 (en) * 2002-10-11 2007-03-27 Queen's University At Kingston Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage
DE10306992A1 (de) * 2003-02-19 2005-08-11 Klinikum der Universität München Großhadern-Innenstadt Verfahren zur quantitativen Messung von Liganden in der Probe gelöster Bindungsproteine
EP1681983A4 (en) * 2003-10-14 2008-12-10 Monogram Biosciences Inc RECEPTOR TYROSINE KINASE SIGNAL PATH ANALYSIS FOR DIAGNOSIS AND THERAPY
EP1524523A1 (en) 2003-10-17 2005-04-20 Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts Use of ADAM 12 for diagnosis and therapy of preeclampsia
CL2007002502A1 (es) 2006-08-31 2008-05-30 Hoffmann La Roche Variantes del factor de crecimiento similar a insulina-1 humano (igf-1) pegilados en lisina; metodo de produccion; proteina de fusion que la comprende; y su uso para tratar la enfermedad de alzheimer.
BRPI0715754A2 (pt) 2006-08-31 2013-07-09 Hoffmann La Roche mÉtodo para a produÇço de fator do crescimento similar Á insulina i
CN101965516A (zh) * 2008-04-03 2011-02-02 弗·哈夫曼-拉罗切有限公司 聚乙二醇化胰岛素样生长因子测定
US20130130283A1 (en) * 2010-03-23 2013-05-23 Imba - Institut Fur Molekulare Biotechnologie Gmbh Methods for Identifying Inhibitors of the Type III Secretion System
US20130338033A1 (en) * 2011-01-27 2013-12-19 Virginia Commonwealth University Diagnostic and Prognostic Markers for Metastasis
CN102830223A (zh) * 2012-08-14 2012-12-19 四川汇宇制药有限公司 一种筛选治疗哺乳动物肿瘤疾病药物的方法
US20140234987A1 (en) 2013-01-02 2014-08-21 N-Dia, Inc. Methods for predicting time-to-delivery in pregnant women
CA2942281C (en) * 2014-03-26 2023-03-14 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassay utilizing three antibodies and methods of production and use thereof
JP7077229B2 (ja) * 2015-12-31 2022-05-30 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッド 非組み換えヒトインスリン様成長因子結合タンパク質の濃縮物
EP3397644A4 (en) * 2015-12-31 2018-12-19 Siemens Healthcare Diagnostics Inc. Non-recombinant human insulin-like growth factor binding protein concentrate
RU2620541C1 (ru) * 2016-04-13 2017-05-26 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ прогнозирования недостаточности гормона роста у пациентов после проведенной в детстве лучевой и полихимиотерапии опухолей задней черепной ямки
US10656164B2 (en) 2016-12-22 2020-05-19 Qiagen Sciences, Llc Screening asymptomatic pregnant woman for preterm birth
US10935555B2 (en) 2016-12-22 2021-03-02 Qiagen Sciences, Llc Determining candidate for induction of labor
CN107991492A (zh) * 2017-11-17 2018-05-04 广州赛莱拉干细胞科技股份有限公司 一种胰岛素样生长因子结合蛋白-3的定量检测试剂盒及其非诊断目的的检测方法
JP2023503105A (ja) * 2019-11-21 2023-01-26 エンテラ・エッセ・エッレ・エッレ Ｉｇｆｂｐ３抗体及びその治療的使用
CN117288966B (zh) * 2023-11-27 2024-02-27 山东康华生物医疗科技股份有限公司 一种联合检测igf-1和igfbp-3的试剂盒及其所用裂解液、缓冲液

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271140A (en) * 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays

Also Published As

Publication number Publication date
CA2323450C (en) 2005-02-08
DE69927255D1 (de) 2005-10-20
US6248546B1 (en) 2001-06-19
EP1070255A4 (en) 2002-10-23
EP1070255A1 (en) 2001-01-24
RU2206897C2 (ru) 2003-06-20
AU760099B2 (en) 2003-05-08
ES2249887T3 (es) 2006-04-01
ATE304708T1 (de) 2005-09-15
AU2996599A (en) 1999-09-27
DE69927255T2 (de) 2006-06-14
WO1999046597A1 (en) 1999-09-16
EP1070255B1 (en) 2005-09-14
CA2323450A1 (en) 1999-09-16
NZ507400A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
DK1070255T3 (da) Fremgangsmåde til detektering af komplekset af IGFBP-3 med IGF og/eller ALS
DK1151304T3 (da) Fremgangsmåde til påvisning af N-terminalt proBNP
ATE223054T1 (de) Assay unter verwendung von porositätsverminderung zur verhinderung von migration
DK1016867T3 (da) Fremgangsmåde til immunassay af BNP
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
DE69132864T2 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
DK0492499T3 (da) Fremgangsmåde til bestemmelse af en analyt
Ishikawa et al. Novel and sensitive noncompetitive (two-site) immunoassay for haptens with emphasis on peptides
Billiar et al. Identification of biologically active inhibin in the peritoneal fluid of women
AU561726B2 (en) Determination of luteinisng hormone and monoclonal antibodies thereto
LABEL FOR CLINICAL CHEMISTRY